Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Technologies Inks Licensing Deal with RIKEN

NEW YORK, Nov. 13 – Third Wave Technologies has licensed over 3,300 genetic markers from Japan’s Institute of Physical and Chemical Research, the organizations announced Tuesday.

The agreement gives Third Wave Technologies, based in Madison, Wis., the worldwide license, excluding Japan, to research and clinical diagnostic applications to patents for genetic markers within approximately 200 genes related to drug metabolism regulation, according to the company.

Financial details of the agreement were not disclosed, though a Third Wave spokesperson told GenomeWeb that the deal included an upfront payment and royalties, and that Third Wave would hold the license as long as the Institute of Physical and Chemical Research, or RIKEN, holds the patents to the markers.

The markers were discovered as part of the of the Japanese government’s SNP Initiative, according to Third Wave. Third Wave plans to use the markers in a series of its Invader genetic variation analysis products for research and clinical diagnostic applications. 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.